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Summary
Epidermal cell migration is critical for restoration of tissue
structure and function after damage [1]. However, the mech-
anisms by which differentiated cells neighboring the wound
sense the wound and assume a motile phenotype remain
unclear. Here, we show that Pvr, a receptor tyrosine kinase
(RTK) related to platelet-derived growth factor (PDGF) and
vascular endothelial growth factor (VEGF) receptors, and
one of its ligands, Pvf1, are required for epidermal wound
closure. Morphological comparison of wound-edge cells
lacking Pvr or the Jun N-terminal kinase (JNK) signaling
pathway previously implicated in larval wound closure [2]
suggests that Pvr signaling leads wound-margin epidermal
cells to extend actin-based cell processes into the wound
gap while JNK mediates transient dedifferentiation of cells
at the wound margin. Genetic epistasis experiments rein-
force the conclusion that the JNK and Pvr signaling path-
ways act in parallel. Tissue-specific knockdown and rescue
experiments suggest that epidermally derived Pvf1 may be
sequestered in the blood and that tissue damage exposes
blood-borne Pvf1 to Pvr receptors onwound-edge epidermal
cells and initiates the extension of cell processes into the
wound gap. These results uncover a novel mechanism of
sensing tissue damage and suggest that PDGF/VEGF
ligands and receptors may play a conserved autocrine role
in epidermal wound closure.
Results and Discussion
Pvr Is Required for Epidermal Wound Closure
A number of RTK ligands and receptors have been implicated in
vertebrate wound closure [3–6]. To identify the signals that
initiate epidermal wound closure, we tested homologs of RTK
candidate genes that had been implicated in diverse aspects
of vertebrate wound closure by using a larval Drosophila
wound-healing assay. We used a larval epidermal Gal4 driver
(Figure S1 available with this article online demonstrates tissue
specificity of this and other Gal4 drivers used in this study) to
drive expression of UAS-RNAi or UAS-dominant-negative
(DN) versions of RTKs implicated in epidermal [4, 5] or mesen-
chymal and endothelial responses to wounding [7–9]. Surpris-
ingly, interference with epidermal growth factor (EGF) or fibro-
blast growth factor (FGF) receptor signaling had no effect on
*Correspondence: mjgalko@mdanderson.orgepidermal morphology or wound closure (Figure 1A and data
not shown). By contrast, expression of UAS-PvrRNAi led to
a near-total block of wound closure (Figures 1A and 1B) similar
to that observed upon inhibition of epidermal JNK signaling
(Figure 1A). Simultaneous overexpression of the full-length
Pvr cDNA rescued the wound-closure defect of UAS-PvrRNAi
(Figure 1A) and suggested that the wound-closure defect was
not a result of off-target effects, as did the wound-closure
defect of an RNAi-independent hypomorphic allele of Pvr,
Pvrc02859 (Figure 1C).
Pvr Is an Epidermal Membrane Protein Whose Expression
Is Regulated by Wounding and Is Greatly Reduced by
Expression of UAS-PvrRNAi
To examine Pvr expression and activation, we immunostained
dissected larval wholemounts with anti-Pvr [10] or anti-di-
phospho-ERK antibodies and found that Pvr protein is local-
ized to the plasma membranes outlining epidermal cell-cell
contacts, similar to other epidermal membrane markers (Fig-
ure S2). Surprisingly, UAS-PvrRNAi expression did not affect
wound-induced appearance of dp-ERK staining, a common
readout of RTK activation (Figure S3). Importantly, epidermal
expression of UAS-PvrRNAi resulted in a complete knockdown
of Pvr protein in the epidermal cell membranes with no effect
on an independent membrane marker, fasciclin III (Figures
1B0 and 1B00), or on Pvr expression in other tissues not affected
by the larval epidermal Gal4 driver (data not shown). Pvr
protein is also absent from epidermal membranes of larvae
homozygous for the Pvrc02859 allele (Figures 1C0 and 1C00) but
is retained in larvae bearing the silent Pvrc03211 allele that
does not affect wound closure (Figures 1D0 and 1D00). To deter-
mine the distribution of Pvr protein along the apico-basal axis,
we used confocal microscopy to view wholemounts of
dissected unwounded larvae expressing a Neuroglian-GFP
fusion protein (Nrg-GFP) and costained for the apical marker
DE-cadherin (Figure S2). Both Nrg-GFP and Pvr were more
broadly localized along the apico-basal axis than DE-cadherin
(Figure S2). Pvr protein levels 4 hr after wounding increased
along epidermal cell borders proximal to the wound (Fig-
ure S2), suggesting that transcriptional upregulation or in-
creased translation may be important for Pvr to promote effi-
cient healing. This increase in Pvr levels was not dependent
on JNK signaling, because it persisted in larvae expressing a
UAS-bskRNAi transgene within the epidermal sheet (Figure S2).
The Pvr and JNK Signaling Pathways Control Distinct
Cellular Aspects of Wound Closure
The JNK signaling pathway is also required for larval wound
closure [2], and a recent study of thorax closure in Drosophila
suggested that Pvr can act upstream of JNK [11]. To under-
stand the specific functions of JNK and Pvr signaling in larval
wound closure, we analyzed the morphology of wounded
larvae expressing UAS-bskDN and UAS-PvrRNAi by transmis-
sion electron microscopy (TEM) and by wholemount staining
for the actin cytoskeleton. In control larvae, leading edge cells
detach from the overlying cuticle and extend long thin
processes that appear to use the debris in the wound gap as
a substrate for migration (Figures 2A and 2B). These processes
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75 mm (Figure 2A and data not shown). They appear to be actin
based, because anti-GFP staining of control larvae expressing
a UAS-actin-GFP transgene [12] within the larval epidermis
exhibited numerous actin-based protrusions extending into
the wound gap (Figure S4). While extending processes, the
epidermal cells cease secreting apical cuticle (Figure 2B).
However, once closure is complete, they secrete a new cuticle
that traps much of the debris in the original wound gap (Fig-
ure 2C).
In larvae expressing UAS-PvrRNAi, the leading edge cell
forms a large cytoplasmic bulge where it detaches from the
overlying cuticle (Figure 2D), indicating that it cannot extend
a normal thin process into the wound gap. Additionally,
labeling of the actin cytoskeleton in UAS-PvrRNAi- and UAS-
actin-GFP- expressing larvae showed a marked decrease in
wound-margin actin levels and in the density of actin-based
protrusions extending from the wound edge (Figure S4). In
contrast, larvae expressing UAS-bskDN or UAS-bskRNAi in
marginal cells extend a thin process that attempts to enter
the wound gap, but this process continues to secrete cuticle,
often causing it to double back toward the epidermal
sheet (Figure 2E and data not shown). At the level of actin
Figure 1. Pvr Is an Epidermal Membrane Protein Required for Wound
Closure
(A) Percentage of larvae of each genotype that showed a defect in epidermal
wound closure when knocked down via UAS-RNAi or a UAS-dominant
negative transgene. n = 30.
(B–D) Dissected epidermal wholemounts immunostained with anti-fasciclin
III (top panels, red) to label membranes and reveal wound architecture 24 hr
after wounding. Scale bar in (D) for (B)–(D) represents 100 mm.
(B) Larva expressing epidermal UAS-PvrRNAi. An open wound persists.
(B0 and B00) An unwounded larva of the same genotype expresses epidermal
fasciclin III (B0, green) but not Pvr (B00, red).
(C) Larva homozygous for Pvrc02859. An open wound persists.
(C0 and C00) An unwounded larva of the same genotype expresses epidermal
fasciclin III (C0, green) but not Pvr (C00, red).
(D) Larva homozygous for Pvrc03211. Wound closure is normal.
(D0 and D00) An unwounded larva of the same genotype expresses epidermal
fasciclin III (D0, green) and Pvr (D00, red).visualization, larvae expressing UAS-bskRNAi showed a
brighter concentration of actin at the wound edge and did
exhibit actin-based protrusions (Figure S4). This closer anal-
ysis of the loss-of-function phenotypes of Pvr and bsk indi-
cates that these signaling pathways likely act in parallel to
control distinct cellular facets of epidermal wound closure.
This conclusion is strengthened by two other experimental
approaches. First, genetic reporters of JNK pathway activity
[2, 13, 14] are activated normally in the wounded UAS-
PvrRNAi-expressing epidermis (Figure S5). Second, gain-of-
function alleles of both pathways also lead to distinct cellular
phenotypes when conditionally expressed in the larval
epidermis (Figure S6).
Epidermally Produced Pvf1 Ligand Is Necessary
for Wound Closure
We next sought to determine the relevant ligand for Pvr during
wound closure. Three genes encode secreted PDGF/VEGF-
like ligands in the Drosophila genome: Pvf1, Pvf2, and Pvf3
[15, 16]. Of these, only Pvf1 has been shown to physically
interact with Pvr [16] and to control migration of epithelial cells
[10, 16]. More than 90% of heterozygous Pvf1null/+ female
larvae healed wounds properly (Figures 3A and 3D), whereas
hemizygous Pvf1null/Y male larvae exhibited a fully penetrant
wound-closure defect (Figures 3B and 3D). By contrast, larvae
homozygous for hypomorphic loss-of-function alleles of Pvf2
and Pvf3 (Pvf2c06947 and Pvf3EY09531) showed no defects in
wound closure (Figure 3D).
To test whether the epidermis is the cellular source of the
Pvf1 protein required for closure, we crossed flies bearing a
UAS-Pvf1RNAi transgene [17] to flies bearing a larval epidermal
Gal4 driver, and progeny larvae were wounded; 23% of
larvae expressing the UAS-Pvf1RNAi transgene via the larval
epidermal A58-Gal4 driver exhibited open wounds (Figures
3C and 3D). To increase the duration of Pvf1 knockdown, we
crossed UAS-Pvf1RNAi flies to flies carrying the slightly weaker
e22c-Gal4 driver (Figure S1), which begins driving expression
in epidermal cells during embryogenesis [18]. Earlier knock-
down increased the percentage of open wounds to 87%
(Figure 3D), suggesting that it is primarily epidermal Pvf1
produced prior to wounding that acts during wound closure.
That Pvf1 might be the only VEGF-like ligand required for
wound closure is further supported by the observation that
epidermal expression of UAS-Pvf2RNAi or UAS-Pvf3RNAi trans-
genes via the e22c-Gal4 driver did not perturb wound closure
(Figure 3D).
Epidermal Overexpression of Pvf1 Perturbs
Wound Closure
Pvf1 acts as a chemoattractant for embryonic blood cells and
migrating border cells during Drosophila oogenesis [10, 15,
16]. If Pvf1 functions as a chemoattractant for leading edge
cells, we reasoned that uniform epidermal expression of this
ligand should interfere with the local concentration gradient
formed after wounding and disrupt closure. Consistent with
this idea, we found that only larvae overexpressing Pvf1 (but
not larvae overexpressing Pvf2 or Pvf3) in the epidermis ex-
hibited defective wound closure (Figures 4B and 4G) and
that epidermal overexpression of Pvf1 in a Pvf1null mutant
background could not rescue the null mutant wound-closure
defect (Figures 4A, 4C, and 4G). Paradoxically, pan-epidermal
overexpression of activated or wild-type Pvr was lethal.
However, we also found that lowering the level of Pvf1 overex-
pression resulted in a partial rescue of the Pvf1null mutant
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ence with wound closure is a function of the level of Pvf1
expression. Taken together, these results argue that Pvf1 nor-
mally activates Pvr only at the wound edge and that endoge-
nous Pvf1 produced by the unwounded epidermis is efficiently
sequestered from Pvr. These results further suggest that Pvf2
and Pvf3 are not capable of activating Pvr within the epidermal
sheet.
Systemic Expression of Pvf1 Rescues the Pvf1null Mutant
Wound Closure Defect
Because vertebrate VEGF and PDGF ligands can be released
into circulating blood [19], we hypothesized that epidermal
cells might secrete Pvf1 across the basal lamina and into the
underlying hemolymph (blood) in order to sequester the ligand
from epidermal Pvr. We further reasoned that if Pvf1 were
a blood protein, then we might be able to rescue the wound-
closure defect of Pvf1null mutant larvae by expressing Pvf1 in
the fat body/oenocytes, tissues that normally produce larval
serum proteins [20] and are separated from the epidermis by
a basal lamina and the blood filling the open body cavity.
Indeed, we found that overexpression of UAS-Pvf1 via a fat
body/oenocyte-specific Gal4 driver (Figure S1) did not inter-
fere with normal wound closure (Figures 4E and 4G) but could
rescue the wound-closure defect of Pvf1null mutant larvae
(Figures 4F and 4G). The lack of a wound-closure defect
upon expressing UAS-Pvf1RNAi via the same fat body/oeno-
cyte driver (Figure 3D), coupled with the nearly fully penetrant
wound-closure defect observed upon epidermal expression of
UAS-Pvf1RNAi (Figure 3D), suggests that the fat body and oe-
nocytes do not normally contribute to the pool of Pvf1 used
during normal wound closure. Similar rescue experiments
with a blood cell-specific Gal4 driver, hmlD-Gal4 (Figure S1),
showed that producing Pvf1 from these cells, which circulate
within the larval body cavity, did not interfere with wound
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Figure 2. The JNK and Pvr Signaling Pathways
Control Distinct Cellular Aspects of Wound
Closure
TEM of transverse sections of epidermal whole-
mounts of pinch-wounded larvae. Control larvae
(A–C) contained either w; Pxn-Gal, UAS-nlacZ
(A-B) or w;; A58-Gal4, UAS-nlacZ to mark the
wound site for sectioning. The following abbrevi-
ations are used: d, wound site debris; e,
epidermis; m, muscle; nc, new cuticle; oc, old
cuticle; arrow, direction of original wound gap.
All scale bars represent 10 mm. Scale bar in (C)
is for (B) and (C); scale bar in (E) is for (D) and (E).
(A) Control larva, 8 hr after wounding. Arrowhead
indicates point of detachment from overlying
cuticle. Bracket indicates 50 mm thin process
extending underneath cellular debris and into
the wound gap.
(B) Control larva, 4 hr after wounding. Arrowhead,
as in (A). Note close apposition of process and
wound site debris.
(C) Control larva, 16 hr after wounding. A new
cuticle traps wound-site debris between itself
and the old cuticle. Arrowhead, point of diver-
gence between new and old cuticles.
(D) Larva expressing UAS-PvrRNAi in the
epidermis. Asterisk represents cytoplasmic
bulge of leading edge cell. Arrowhead, as in (A).
(E) Larva expressingUAS-bskDN in the epidermis.
Arrowhead represents terminus of cell process
that continues to secrete cuticle.
Figure 3. Epidermally Produced Pvf1 Ligand Is Required for Wound Closure
(A–C) w, UAS-dsRed2Nuc, A58-Gal4 heterozygous larvae were pinch-
wounded, dissected, fixed and immunostained for fasciclin III (green)
24 hr after wounding. Red, epidermal nuclei. Scale bar in (C) for (A)–(C)
represents 100 mm.
(A) Female larva heterozygous for Pvf1null. Wound closure is normal.
(B) Male larva hemizygous for Pvf1null. An open wound persists.
(C) Larva in which A58-Gal4 drives pan-epidermal expression of UAS-
Pvf1RNAi. An open wound persists.
(D) Percentage of larvae of each genotype that showed a defect in epidermal
wound closure. Larvae mutant for Pvf1 or expressing UAS-Pvf1RNAi within
the epidermis show defects in wound closure, whereas larvae mutant for
Pvf2 or expressing UAS-Pvf2RNAi or larvae mutant for Pvf3 or expressing
UAS-Pvf3RNAi show no defects in wound closure. By contrast, fat body or
blood cell expression of UAS-Pvf1RNAi does not perturb wound closure
(middle). n = 30.
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closure defect of Pvf1null mutant larvae (Figure S8). As with
the fat body, blood cell-specific expression of UAS-Pvf1RNAi
did not block epidermal wound closure (Figure 3D). Taken
together, these results suggest that, although the epidermis
is the tissue source of Pvf1 during normal wound closure,
ectopic production of this protein in the blood can restore
a functional wound-closure response in aPvf1null mutant back-
ground.
A Working Model for How the Larval Epidermis Senses
and Responds to Tissue Damage
Pvr is required for diverse developmentally programmed cell
migrations, including blood cell migrations during embryogen-
esis [15, 21], thorax closure during metamorphosis [11], and
border cell migration during oogenesis [10, 16]. The latter
migration is arguably the most intensively studied, with
oocyte-expressed Pvf1 protein proposed to serve as a cellular
source of chemoattractant for Pvr-expressing border cells
migrating in a cluster from the anterior follicular epithelium.
Figure 4. The Proper Spatial Presentation of Pvf1 Is Required for
Wound Closure
(A–F) Dissected epidermal wholemounts immunostained with anti-
fasciclin III (red). Scale bar in (F) for (A)–(F) represents 100 mm.
(A) Pvf1null/Y male larvae with A58-Gal4. Open wound.
(B) Larva in which A58-Gal4 drives pan-epidermal expression of
UAS-Pvf1. Open wound.
(C) Larva in which A58-Gal4 drives pan-epidermal expression of
UAS-Pvf1 in a Pvf1null mutant background. Ectopic Pvf1 expression
in the epidermis fails to rescue the wound-closure defect of Pvf1null.
(D) Pvf1null/Y male larvae with Fat body-Gal4. Open wound.
(E) Larva in which Fat body-Gal4 drives expression of UAS-Pvf1.
Closed wound.
(F) Expression of UAS-Pvf1 via Fat body-Gal4 in a Pvf1null mutant
background. Ectopic Pvf1 expression rescues the wound-closure
defect of Pvf1null.
(G) Percentage of larvae of each genotype that showed a defect in
wound closure. Expression of UAS-Pvf1 via epidermal A58-Gal4
completely blocks wound closure, expression from the weaker
e22c-Gal4 driver gives a partial block, and expression from Fat
body-Gal4 rescues the wound-closure defect of the Pvf1null mutant.
By contrast, epidermal overexpression of Pvf2 (Pvf2d02444) or Pvf3
(UAS-Pvf3) does not block wound closure. n = 30.
Figure 5. Model of Pvr and JNK Signaling in
Larval Epidermal Wound Closure
Pvr signaling (green, left side of wound) controls
cell process extension into the debris-filled
(brown) wound gap. Hemolymph-borne Pvf1
(green circles) originally produced by the
epidermis (blue cells) binds to exposed Pvr
receptors (green glyphs) at the wound edge to
activate signaling. JNK signaling (red, right side
of wound) is activated through an as yet undis-
covered ligand (red diamonds) and receptor (red glyphs) or mechanical signal. Once JNK is activated, it suppresses secretion of and attachment to cuticle
(purple) near the wound gap. The thick black line represents basal lamina. At a real wound, both pathways would be active at all wound margins. See text for
details.
In border cells, Pvr and the EGF receptor (DER) are not
required for formation of actin-based protrusions but
rather act together to ensure directionality of the
migrating cell cluster [22]. Here we implicate Pvr and
Pvf1 in a physiologically induced cell migration and
propose a working model for how Drosophila larvae
sense damage to the barrier epithelium in the absence
of an epidermal source of ligand within the wound gap
(Figure 5).
The unwounded epidermal sheet expresses both Pvr, which
is localized to lateral epidermal cell-cell contacts, and, on the
basis of our tissue-specific RNAi experiments, the Pvr ligand,
Pvf1, which we propose is segregated from Pvr by secretion
across the basal lamina and into the blood filling the open
body cavity. When tissue injury creates a gap in the epidermal
sheet and underlying basal lamina, we envision a number of
events ensuing. First, Pvr receptors on lateral epidermal
membranes facing the wound gap would now be exposed to
blood-borne Pvf1 ligand and could thus be activated. Subse-
quent to ligand binding, we infer that the actin polymerization
machinery within the cell is locally activated so that the cell can
extend processes in the direction of the wound gap. Because
the basal lamina underlying the rear of the cell remains intact
(data not shown), Pvr receptors would be activated only on
the side of the cell facing the wound gap, and this could
elegantly explain how epidermal cells polarize and extend
processes only in this direction, regardless of which side of
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based protrusion observed here differs somewhat from the
recently described role of the RTK Stitcher in actin cable
formation in the healing fly embryo [23]. It is also different
from its shared role with DER in border cell migration [22],
but this may simply be a result of cell type specificity and
differences in gene expression or activation of as yet unidenti-
fied Pvr downstream signaling components.
Alternative models are conceivable. For example, Pvf1
might be produced in an inactive form by undamaged epi-
dermal cells, with wounding somehow locally activating the
ligand. However, this possibility would not well explain the
data indicating that ectopic overexpression of the ligand in
the epidermis can block wound closure and that overexpres-
sion of wild-type Pvr in the epidermal sheet is lethal. The latter
observation in particular suggests that Pvf1 can activate Pvr
even in the absence of wounding. Thus, we favor our current
model because it plausibly reconciles the ability of systemic
Pvf1 to rescue the wound-closure defect of Pvf1null mutants
with the fact that the epidermis is the tissue source of func-
tional Pvf1 ligand. We look forward to pursuing the testable
predictions raised by our working model and other possible
alternatives.
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